Should I continue taking dydrogesterone if bleeding occurs during treatment?

Generally, if bleeding occurs during the use of dydrogesterone, whether to continue taking the medication depends on the cause and specific circumstances. The detailed analysis is as follows:

If dydrogesterone is being taken to treat conditions such as luteal phase deficiency or threatened miscarriage, and the bleeding is light and spotting in nature, without abdominal pain or other discomfort, and examination confirms normal embryonic development with a continued need for hormonal supplementation, then the medication may be continued under a doctor's guidance. In such cases, the bleeding is often a temporary manifestation as the body adjusts to the medication or during recovery, and continuing treatment helps maintain hormonal stability and supports symptom relief.

If the bleeding is heavy during dydrogesterone use—similar to menstrual flow or progressively increasing—and accompanied by symptoms such as abdominal pain or lower back soreness, or if examinations reveal abnormal embryonic development or normalized hormone levels, continuing the medication is not recommended. The drug should be stopped immediately, and medical attention sought to determine whether the bleeding is due to drug side effects or changes in the underlying condition, thus avoiding delays in appropriate management.

In daily life, adequate rest is important. Avoid strenuous exercise and heavy physical labor to reduce bodily strain. Maintain good external genital hygiene by gently cleaning with warm water and frequently changing cotton underwear to prevent infection. Follow a light, nutritious diet rich in protein and vitamins to help maintain overall health. Closely monitor any bleeding, recording the amount, color, and associated symptoms, so that detailed information can be provided during medical consultations.